Automation for blood fractionation: Quicker, more efficient, and saferThe demand for blood plasma and other blood products is constantly increasing, but the raw material blood is becoming increasingly scarce. Therefore, efficiency, quality, and performance are important issues in blood fractionation.utomation for blood fractionation: Quicker, more efficient, and saferThe demand for blood plasma and other blood products is constantly increasing, but the raw material blood is becoming increasingly scarce. Therefore, efficiency, quality, and performance are important issues in blood fractionation.
It is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost. The lowest GoodRx price for the most common version of Basaglar is around $331.94, 15% off the average retail price of $392.68.
Basaglar is the first âbiosimilarâ insulin product to be approved in the US, and despite the delay, is expected to be the first biosimilar insulin to launch in the US as well. Other companies including Mylan/Biocon and Merck/Samsung Bioepis are working on their own biosimilar insulin glargine products.